XS Innovations is tackling a major challenge for people with end-stage kidney disease: keeping their blood vessel access open for dialysis. Most patients need a special connection between an artery and a vein in their arm, called an arteriovenous fistula (AVF), to ensure enough blood flows during treatment. 

Although the National Growth Fund has officially concluded following its third round of funding, several million euros remain available for promising new initiatives—especially in the field of Health & Care.

Liver toxicity is the number one reason for drugs to be retracted from the market. More reliable methods for predicting drug- induced liver toxicity will not only save drug development costs by detecting liver toxic drugs earlier, but will also spare patients from potential severe side effects due to liver toxicity.